Analysis of cationic-lipid-plasmid-DNA complexes

Analytical Chemistry

Volumn 79, Issue 19, 2007, Pages 7240-7248

  Middaugh, C Russell ^a   Ramsey, Joshua B ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATION; PLASMID DNA;

CIRCULAR DICHROISM; DIFFERENTIAL SCANNING CALORIMETRY; DNA HELIX; FLUORESCENCE SPECTROSCOPY; GEL ELECTROPHORESIS; GENE THERAPY; HYDROLYSIS; IONIC STRENGTH; ISOTHERMAL TITRATION CALORIMETRY; LIGHT SCATTERING; MOLECULAR STABILITY; PROTEIN STRUCTURE; REVIEW; ULTRACENTRIFUGATION;

CATIONS; DNA; GENE THERAPY; GENE TRANSFER TECHNIQUES; LIPIDS; PLASMIDS;

EID: 35348943833     PISSN: 00032700     EISSN: None     Source Type: Journal    
DOI: 10.1021/ac0719711     Document Type: Review

References (63)

1. Hollon, T. Am. J. Ophthalmol. 2000, 129, 701.
2. Kohn, D. B.; Sadelain, M.; Glorioso, J. C. Nat. Rev. Cancer 2003, 3, 477-488.
3. Gottschalk, S.; et al. Gene Ther. 1996, 3, 448-457.
4. Boussif, O.; et al. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 7297-7301.
5. Kukowska-Latallo, J. F.; et al. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 4897-4902.
6. Wolfert, M. A.; et al. Hum. Gene Ther. 1996, 7, 2123-2133.
7. Felgner, P. L.; et al. Proc. Natl. Acad. Sci. U.S.A. 1987, 84, 7413-7417.
8. Liang, H.; Harries, D.; Wong, G. C. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 11,173-11,178.
9. Tousignant, J. D.; et al. Hum. Gene Ther. 2000, 11, 2493-2513.
10. Dow, S. W.; et al. J. Immunol. 1999, 163, 1552-1561.
11. Pedroso de Lima, M. C.; et al. Adv. Drug Deliv. Rev. 2001, 47, 277-294.
12. Dass, C. R. J. Mol. Med. 2004, 82, 579-591.
13. Wasungu, L.; Hoekstra, D. J. Controlled Release 2006, 116, 255-264.
14. Ravanat, J. L.; et al. Chem. Res. Toxicol. 1995, 8, 1039-1045.
15. Cui, L.; Zhu, L. Langmuir 2006, 22, 5982-5985.
16. Radler, J. O.; et al. Science 1997, 275, 810-814.
17. Koltover, I.; et al. Science 1998, 281, 78-81.
18. Fang, Y.; Yang, J. J. Phys. Chem. B 1997, 101, 441-449.
19. Sternberg, B.; Sorgi, F. L.; Huang, L. FEBS Lett. 1994, 356, 361-366.
20. Huebner, S.; et al. Biophys. J. 1999, 76, 3158-3166.
21. Lin, A. J.; et al. Biophys. J. 2003, 84, 3307-3316.
22. Caracciolo, G.; et al. Langmuir 2007, 23, 4498-4508.
23. Wiethoff, C. M.; et al. J. Biol. Chem. 2002, 277, 44,980-44,387.
24. Wiethoff, C. M.; et al. J. Pharm. Sci. 2004, 93, 108-123.
25. Ruponen, M.; Braun, C. S.; Middaugh, C. R. J. Pharm. Sci. 2006, 95, 2101-2114.
26. Mislick, K. A.; Baldeschwieler, J. D. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 12,349-12,354.
27. Wiethoff, C. M.; et al. J. Biol. Chem. 2001, 276, 32,806-32,813.
28. Smith, J. G.; et al. Pharm. Res. 1998, 15, 1356-1363.
29. Xu, Y.; et al. Biophys. J. 1999, 77, 341-353.
30. Lesage, D.; et al. Biochim. Biophys. Acta 2002, 1564, 393-402.
31. Farhood, H.; et al. Biochim. Biophys. Acta 1992, 1111, 239-246.
32. Braun, C. S.; et al. Biophys. J. 2003, 84, 1114-1123.
33. Choosakoonkriang, S.; et al. J. Pharm. Sci. 2003, 92, 1710-1722.
34. Lobo, B. A.; et al. J. Pharm. Sci. 2003, 92, 1905-1918.
35. Braun, C. S.; et al. J. Pharm. Sci. 2005, 94, 423-436.
36. Choosakoonkriang, S.; et al. In Nonviral Vectors for Gene Therapy: Methods and Protocols; Findeis, M. A., Ed.; Humana Press: Totowa, NJ, 2001; Vol. 65, pp 285-317.
37. Choosakoonkriang, S.; et al. J. Biol. Chem. 2001, 276, 8037-8043.
38. Choosakoonkriang, S.; et al. J. Pharm. Sci. 2003, 92, 115-130.
39. Wiethoff, C. M.; et al. J. Pharm. Sci. 2003, 92, 1272-1285.
40. Förster, Th. Ann. Phys. 1948, 437, 55-75.
41. Selvin, P. R. Nat. Struct. Biol. 2000, 7, 730-734.
42. Madeira, C.; et al. Biophys. J. 2003, 85, 3106-3119.
43. Zhang, Y.; et al. Biochim. Biophys. Acta 2003, 1614, 182-192.
44. Braun, C. S.; et al. Biophys. J. 2005, 88, 4146-4158.
45. Braun, C. S.; Kueltzo, L. A.; Middaugh, C. R. In Nonviral Vectors for Gene Therapy: Methods and Protocols; Findeis, M. A., Ed.; Humana Press: Totowa, NJ, 2001; Vol. 65, pp 253-284.
46. Lobo, B. A.; et al. In Nonviral Vectors for Gene Therapy: Methods and Protocols; Findeis, M. A., Ed.; Humana Press: Totowa, NJ, 2001; Vol. 65, pp 319-348.
47. Wiethoff, C.; Middaugh, C. R. In Nonviral Vectors for Gene Therapy: Methods and Protocols; Findeis, M. A., Ed.; Humana Press: Totowa, NJ, 2001; Vol. 65, pp 349-376.
48. Ausar, S. F.; Joshi, S. B.; Middaugh, C. R. In Gene Therapy Protocols, 3rd ed.; Walker, J. M., Le Doux, J., Eds.; Humana Press: Totowa, NJ, 2007, in press.
49. Singh, M.; Kisoon, N.; Ariatti, M. Drug Deliv. 2001, 8, 29-34.
50. Moret, I.; et al. J. Controlled Release 2001, 76, 169-181.
51. Bates, A. D.; Maxwell, A. DNA Topology, 2nd ed.; Oxford University Press: New York, 2005.
52. Johnston, B. H.; Rich, A. Cell 1985, 42, 713-724.
53. Palecek, E. Crit. Rev. Biochem. Mol. Biol. 1991, 26, 151-226.
54. Prasad, T. K.; Gopal, V.; Rao, N. M. FEBS Lett. 2003, 552, 199-206.
55. Matulis, D.; Rouzina, I.; Bloomfield, V. A. J. Am. Chem. Soc. 2002, 124, 7331-7342.
56. Lobo, B. A.; et al. Arch. Biochem. Biophys. 2001, 386, 95-105.
57. Pozharski, E.; MacDonald, R. C. Biophys. J. 2002, 83, 556-565.
58. Lobo, B. A.; et al. J. Pharm. Sci. 2002, 91, 454-466.
59. Zhang, Z.; et al. Biophys. Chem. 2002, 97, 7-16.
60. Kueltzo, L. A.; et al. J. Pharm. Sci. 2003, 92, 1805-1820.
61. Ausar, S. F.; et al. J. Biol. Chem. 2006, 281, 19,478-19,488.
62. Ausar, S. F.; et al. Mol. Pharm. 2005, 2, 491-499.
63. Zeng, Y.; Fan, H.; Joshi, S. B.; Middaugh, C. R. 2007, unpublished results.